Skip to main content

Share story

Policy AI

Apple gains broader discovery in OpenAI trade secrets case

Apple gains broader discovery in OpenAI trade secrets case Image: Primary
Judge Edward Davila expanded Apple's access to evidence in its trade secrets lawsuit against OpenAI, io Products and two former Apple employees, 9to5Mac reported. The order follows adoption of a narrower definition of the Apple information covered by discovery. Apple can obtain records concerning former employees' use of AI tools and testimony about hardware development, recruitment and handling of confidential Apple information. Defendants have up to 14 days to produce records and answer questions. Davila denied requests concerning OpenAI's own devices, accounts and internal investigations, along with two corporate testimony requests he found too broad for this stage.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from 9to5Mac and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Former Benchmark investors raise $1.252 billion for Diffusion ONE

Former Benchmark investors Victor Lazarte and Kris Fredrickson have raised $1.252 billion for their debut AI fund, Diffusion ONE, TechCrunch reported from SEC filings. The total exceeds the $800 million target Forbes reported in M...

Products Capital
Products Capital

Hex announces $100 million financing and rebuilt analytics platform

Hex says it closed a $100 million financing round at a $1.2B valuation and introduced Hex 4.0, a rewrite of its analytics platform. PeakXV and 137 Ventures led the round, with participation from Amplify, Avra, a16z, Redpoint, Sequ...

Infrastructure Products
Infrastructure Products

ASM raises 2027 revenue forecast to more than €5.7B

ASM International raised its 2027 revenue forecast to more than €5.7B from above €4.6B forecast in July, as memory and advanced AI chipmakers expand production. The chip-equipment maker said the revised outlook would reach its 203...

Capital AI
Capital AI

Anthropic acquires Mithril Medicine and starts its own drug research

Anthropic says it has acquired Mithril Medicine, a one-person company developing treatments for two rare forms of muscular dystrophy, and begun running drug discovery programs itself. Founder Cody Tranbarger is continuing the rese...